Cleared Traditional

K183148 - OKLand Patient Return Electrode Pad

K183148 is an FDA 510(k) clearance for OKLand Patient Return Electrode Pad, manufactured by Auckland Medical Polymer(Tianjin) Co., Ltd.. The device is a Class 2 General & Plastic Surgery device with product code GEI cleared through the Traditional 510(k) pathway after a 448-day FDA review.

K183148 · Auckland Medical Polymer(Tianjin) Co., Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2020
Decision
448d
Days
Class 2
Risk

K183148 is an FDA 510(k) clearance for the OKLand Patient Return Electrode Pad. Classified as Electrosurgical, Cutting & Coagulation & Accessories within the GEI classification (a category for electrosurgical cutting and coagulation devices), Class II - Special Controls.

Submitted by Auckland Medical Polymer(Tianjin) Co., Ltd. (Tianjin, CN). The FDA issued a Cleared decision on February 4, 2020 after a review of 448 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.

View all Auckland Medical Polymer(Tianjin) Co., Ltd. devices

FDA 510(k) Submission Details - K183148

510(k) Number K183148 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 13, 2018
Decision Date February 04, 2020
Days to Decision 448 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
333d slower than avg
Panel avg: 115d · This submission: 448d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GEI Device Classification - Class 2, Special Controls

Product Code GEI Electrosurgical, Cutting & Coagulation & Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEI Electrosurgical, Cutting & Coagulation & Accessories

All 1256
Devices cleared under the same product code (GEI) and FDA review panel - the closest regulatory comparables to K183148.
Potenza
K192545 · Jeisys Medical Incorporated · Feb 2020
ArtiSential Bipolar Fenestrated Forceps
K190909 · Livsmed, Inc. · Feb 2020
Sutter Swyng non-stick bipolar forceps, single-use
K193587 · Sutter Medizintechnik GmbH · Feb 2020
Viveve 2.0 System
K193611 · Viveve Medical, Inc. · Jan 2020
INTRAcel RF Microneedle System
K183284 · Jeisys Medical, Inc. · Jan 2020
CRF Radiofrequency Ablation System
K192715 · Cambridge Interventional, LLC · Jan 2020